Leaderboards/Renal cell carcinoma treatment

Renal cell carcinoma treatment

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Peter Mulders
Radboud University Nijmegen
81
2
Timothée Olivier
Unknown
77
3
Thomas Powles
Queen Mary University of London
76
4
David A. Braun
Yale Cancer Center
73
5
Michael A. Carducci
Johns Hopkins University
72
6
Sylvan C. Baca
Broad Institute
72
7
Viktor Grünwald
Essen University Hospital
70
8
Amir Mortazavi
The Ohio State University
69
9
Eric Jonasch
The University of Texas MD Anderson Cancer Center
66
10
Nizar M. Tannir
The University of Texas MD Anderson Cancer Center
64

Rising Stars Papers

1
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma
Cell Reports|2024
26 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Serena Porcari
Università Cattolica del Sacro Cuore
87
2
Ricardo Fernandes
Western University
82
3
Chris Labaki
Beth Israel Deaconess Medical Center
80
4
Ramaprasad Srinivasan
National Institutes of Health
73
5
Nicholas G. Cost
Unknown
72
6
Mridula George
Rutgers, The State University of New Jersey
72
7
Kartik Sehgal
Dana-Farber Cancer Institute
72
8
Hao Ning
Chongqing Medical University
69
9
Danil Stupichev
Addgene
65
10
Guangxiang Liu
Nanjing Drum Tower Hospital
65

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Toni K. Choueiri
Université Claude Bernard Lyon 1
99
2
Robert J. Motzer
Memorial Sloan Kettering Cancer Center
98
3
Jennifer A. Wargo
The University of Texas MD Anderson Cancer Center
93
4
Thomas Powles
Queen Mary University of London
88
5
Axel Bex
Royal Free London NHS Foundation Trust
85
6
Bernard Escudier
Institut Gustave Roussy
77
7
Alan Horwich
Institute of Cancer Research
76
8
Quynh‐Thu Le
Stanford University
75
9
Elżbieta Senkus
Gdańsk Medical University
69
10
Linhui Wang
Second Military Medical University
66

All-Time Leaders Papers

1
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Science|2017
4.6k cit.
2
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
New England Journal of Medicine|2018
4.6k cit.
3
B cells and tertiary lymphoid structures promote immunotherapy response
Nature|2020
2.6k cit.
4
BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
Clinical Cancer Research|2013
936 cit.
5
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2022
645 cit.
6
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
Annals of Oncology|2020
457 cit.
7
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Journal of Clinical Oncology|2013
443 cit.
8
Phase III Randomized Trial of Conventional-Dose Chemotherapy With or Without High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Rescue As First-Line Treatment for Patients With Poor-Prognosis Metastatic Germ Cell Tumors
Journal of Clinical Oncology|2007
351 cit.
9
Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade
Cancer Immunology Research|2014
257 cit.
10
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
British Journal of Cancer|2005
230 cit.

Reagents for Renal cell carcinoma treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

IGF-I Receptor alpha (D3A2W) Rabbit Monoclonal Antibody

Cited in 9 papers
#17174$161
View Evidence →Santa Cruz Biotechnology

BAP1 (C-4)

Cited in 8 papers
#sc-28383
View Evidence →Proteintech

PAX8 antibody

Cited in 7 papers
#10336-1-AP$449
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

MTA2 Antibody

Cited in 11 papers
#15793$317
View Evidence →Cell Signaling Technology

Cleaved Caspase-3 (Asp175) Antibody (Alexa Fluor® 488 Conjugate)

Cited in 11 papers
#9669$493
View Evidence →Cell Signaling Technology

CD74 (F6K1S) Rabbit Monoclonal Antibody

Cited in 10 papers
#70167$161
View Evidence →